Alzheimer’s disease is most commonly described in three stages (mild, moderate, and severe), but a more detailed clinical scale breaks it into seven. The answer depends on which staging framework you’re looking at. Doctors, researchers, and caregivers use different models for different purposes, and understanding what each one measures helps you make sense of a diagnosis or plan for what’s ahead.
The Three-Stage Model Most Doctors Use
The most widely referenced framework comes from the National Institute on Aging and the Alzheimer’s Association (NIA-AA), published in 2011. It divides the disease into three broad stages based on how much a person’s daily life is affected:
- Preclinical (asymptomatic) Alzheimer’s: Brain changes are already underway, but the person has no noticeable symptoms. This stage can last years or even decades before anything feels different. It’s only detectable through biomarker testing, not through everyday observation.
- Mild cognitive impairment (MCI) due to Alzheimer’s: Mild changes in memory and thinking are noticeable and measurable on cognitive tests, but they aren’t severe enough to disrupt day-to-day life. People at this stage can still take care of themselves and carry out normal activities.
- Dementia due to Alzheimer’s: Memory, thinking, and behavior problems are now significant enough to interfere with a person’s ability to function independently.
This three-stage model is useful for understanding the big picture, but the final stage, dementia, covers an enormous range. Someone who occasionally forgets a friend’s name and someone who can no longer speak are both technically in the “dementia” stage. That’s where more detailed scales become helpful.
The Seven-Stage Scale
The Global Deterioration Scale, developed by Dr. Barry Reisberg in 1982, splits the disease into seven stages based on observable cognitive and functional decline. It gives families and caregivers a more granular sense of where someone falls on the progression.
- Stage 1: No impairment. No memory problems. No symptoms detectable by a clinician.
- Stage 2: Very mild decline. Minor memory lapses, like forgetting familiar words or where you left your keys. These changes are subtle and not detectable during a medical exam.
- Stage 3: Mild decline. Friends and family start noticing difficulties. Trouble finding the right word, remembering names of new acquaintances, or planning and organizing. A clinical interview can pick up on these problems.
- Stage 4: Moderate decline. Clear-cut symptoms appear. Difficulty with arithmetic, forgetting recent events, trouble managing finances or traveling to new places. People at this stage often withdraw socially.
- Stage 5: Moderately severe decline. Major gaps in memory and daily function. A person may not remember their address or phone number, become confused about the date or season, and need help choosing appropriate clothing. They can still eat and use the bathroom independently.
- Stage 6: Severe decline. Memory continues to worsen. A person may forget the name of a spouse or caregiver, need help dressing, and experience significant personality and behavioral changes, including agitation, hallucinations, and repetitive behaviors. Bladder control becomes difficult.
- Stage 7: Very severe decline. The final stage. A person loses the ability to respond to their environment, carry on a conversation, and eventually control movement. Muscles become rigid, swallowing becomes difficult, and full-time care is required.
Stages 1 and 2 on this scale roughly correspond to the preclinical phase in the three-stage model. Stage 3 maps loosely to MCI. Stages 4 through 7 all fall under the broad “dementia” umbrella of the three-stage system, which is why the seven-stage scale is often more practical for families tracking changes over time.
What Each Stage Looks Like in Daily Life
Mild Alzheimer’s
A person in the early symptomatic phase may seem healthy overall but is having increasing trouble making sense of the world around them. The realization that something is wrong tends to come gradually. Common signs include poor judgment leading to bad decisions, trouble handling money and paying bills, repeating questions, losing track of dates, and taking longer than usual to complete routine tasks. Mood and personality shifts often appear here too, with increased anxiety or uncharacteristic aggression.
Moderate Alzheimer’s
This is typically the longest stage and the point where supervision and hands-on care become necessary. Memory loss deepens: a person may forget major events from their own life or occasionally fail to recognize family members. Multistep tasks like getting dressed become difficult. Sleep patterns shift, with more daytime sleeping and restlessness at night. Behavioral symptoms often intensify during this stage, including hallucinations, delusions, paranoia, and impulsive actions. Emotional outbursts and late-afternoon agitation (sometimes called sundowning) are common.
Severe Alzheimer’s
In the final stage, a person loses the ability to communicate and becomes completely dependent on others. They may be in bed most or all of the time. Physical decline accelerates: swallowing becomes difficult, weight drops, bowel and bladder control is lost, and muscles grow rigid. Reflexes stop responding normally. Seizures can occur. Near the end, communication may be limited to groaning or grunting.
How Long Each Stage Lasts
Alzheimer’s progresses differently in every person, so timelines are rough averages rather than fixed schedules. From the first symptoms to end of life, the disease typically runs 8 to 10 years, though it can stretch well beyond that. The preclinical phase, where brain changes are happening silently, may begin 15 to 20 years before any noticeable symptoms.
The mild stage often lasts 2 to 4 years. The moderate stage tends to be the longest, sometimes spanning 2 to 10 years. The severe stage is generally shorter, often 1 to 3 years. Age at diagnosis, overall health, and other medical conditions all influence how quickly someone moves through these phases. Progression is rarely smooth or predictable. A person may seem stable for months and then decline noticeably over a few weeks.
The 2024 Biological Staging Update
In June 2024, the NIA and Alzheimer’s Association published revised criteria that shift the definition of Alzheimer’s from a clinical syndrome to a biological one. Under this framework, Alzheimer’s is diagnosed through biomarkers, proteins detectable in spinal fluid or blood, rather than purely by symptoms. The disease is treated as a continuum that begins with invisible brain changes in asymptomatic people and progresses through increasing levels of biological damage before symptoms emerge.
This matters for two practical reasons. First, blood-based biomarker tests (plasma biomarkers) are now incorporated into the diagnostic criteria, which means detection could eventually happen through a routine blood draw rather than expensive brain scans or spinal taps. Second, with new treatments that target the underlying biology of Alzheimer’s now available, catching the disease at its earliest biological stage becomes more actionable than it was even a few years ago.
For most families navigating a diagnosis today, the three-stage or seven-stage models remain the most useful way to understand what’s happening and what to expect next. The biological framework is increasingly shaping how doctors think about the disease behind the scenes, but the day-to-day reality of caregiving still tracks closely with the symptom-based stages described above.